Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Tethered interleukin-2 to its receptor IL-2RBETA, a platform to enhance natural killer and regulatory T cell activity

Tethered interleukin-2 to its receptor IL-2RBETA, a platform to enhance natural killer and regulatory T cell activity

US Patent 12202856 · Granted Jan 21, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Reversal of general anesthesia by administration of methylphenidate, amphetamine2023
Acyclic cucurbit[n]uril type molecular containers to treat intoxication and decr2018
Etomidate analogues that do not inhibit adrenocortical steroid synthesis2015
Etomidate analogues that do not inhibit adrenocortical steroid synthesis2015
Etomidate analogues that do not inhibit adrenocortical steroid synthesis2015
Etomidate analogues with improved pharmacokinetic and pharmacodynamic properties2015
Etomidate analogues with improved pharmacokinetic and pharmacodynamic properties2015
Etomidate analogues with improved pharmacokinetic and pharmacodynamic properties2015
Etomidate analogues that do not inhibit adrenocortical steroid synthesis2014
Etomidate analogues that do not inhibit adrenocortical steroid synthesis2014
Etomidate analogues that do not inhibit adrenocortical steroid synthesis2014
Etomidate analogues with improved pharmacokinetic and pharmacodynamic properties2013